Correlation Between Protagonist Therapeutics and Veracyte
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Veracyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Veracyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Veracyte, you can compare the effects of market volatilities on Protagonist Therapeutics and Veracyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Veracyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Veracyte.
Diversification Opportunities for Protagonist Therapeutics and Veracyte
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Protagonist and Veracyte is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Veracyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veracyte and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Veracyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veracyte has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Veracyte go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Veracyte
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.59 times more return on investment than Veracyte. However, Protagonist Therapeutics is 1.7 times less risky than Veracyte. It trades about 0.08 of its potential returns per unit of risk. Veracyte is currently generating about -0.28 per unit of risk. If you would invest 3,758 in Protagonist Therapeutics on December 6, 2024 and sell it today you would earn a total of 147.00 from holding Protagonist Therapeutics or generate 3.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Veracyte
Performance |
| Timeline |
| Protagonist Therapeutics |
| Veracyte |
Protagonist Therapeutics and Veracyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Veracyte
The main advantage of trading using opposite Protagonist Therapeutics and Veracyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Veracyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will offset losses from the drop in Veracyte's long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |